Title : The insulin-sensitizing effect of rosiglitazone in type 2 diabetes mellitus patients does not require improved in vivo muscle mitochondrial function.

Pub. Date : 2008 Jul

PMID : 18460571






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The insulin-sensitizing effect of rosiglitazone in type 2 diabetes mellitus patients does not require improved in vivo muscle mitochondrial function. Rosiglitazone insulin Homo sapiens
2 AIMS: Our objective was to investigate whether improved in vivo mitochondrial function in skeletal muscle and intramyocellular lipids (IMCLs) contribute to the insulin-sensitizing effect of rosiglitazone. Rosiglitazone insulin Homo sapiens
3 RESULTS: Insulin sensitivity improved after rosiglitazone (glucose infusion rate: 19.9 +/- 2.8 to 24.8 +/- 2.1 micromol/kg.min; P < 0.05). Rosiglitazone insulin Homo sapiens
4 CONCLUSION: The rosiglitazone-enhanced insulin sensitivity does not require improved muscular mitochondrial function. Rosiglitazone insulin Homo sapiens